Speer, C.; Töllner, M.; Benning, L.; Bartenschlager, M.; Kim, H.; Nusshag, C.; Kälble, F.; Reineke, M.; Reichel, P.; Schnitzler, P.;
et al. BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study. Viruses 2023, 15, 1778.
https://doi.org/10.3390/v15081778
AMA Style
Speer C, Töllner M, Benning L, Bartenschlager M, Kim H, Nusshag C, Kälble F, Reineke M, Reichel P, Schnitzler P,
et al. BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study. Viruses. 2023; 15(8):1778.
https://doi.org/10.3390/v15081778
Chicago/Turabian Style
Speer, Claudius, Maximilian Töllner, Louise Benning, Marie Bartenschlager, Heeyoung Kim, Christian Nusshag, Florian Kälble, Marvin Reineke, Paula Reichel, Paul Schnitzler,
and et al. 2023. "BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study" Viruses 15, no. 8: 1778.
https://doi.org/10.3390/v15081778
APA Style
Speer, C., Töllner, M., Benning, L., Bartenschlager, M., Kim, H., Nusshag, C., Kälble, F., Reineke, M., Reichel, P., Schnitzler, P., Zeier, M., Morath, C., Schmitt, W., Bergner, R., Bartenschlager, R., Lorenz, H.-M., & Schaier, M.
(2023). BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study. Viruses, 15(8), 1778.
https://doi.org/10.3390/v15081778
